| Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition AJ Greaney, TN Starr, P Gilchuk, SJ Zost, E Binshtein, AN Loes, SK Hilton, ... Cell host & microbe 29 (1), 44-57. e9, 2021 | 1091 | 2021 |
| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1083 | 2020 |
| Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein SJ Zost, P Gilchuk, RE Chen, JB Case, JX Reidy, A Trivette, RS Nargi, ... Nature medicine 26 (9), 1422-1427, 2020 | 478 | 2020 |
| Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein N Suryadevara, S Shrihari, P Gilchuk, LA VanBlargan, E Binshtein, ... Cell 184 (9), 2316-2331. e15, 2021 | 381 | 2021 |
| Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, ... Cell 184 (7), 1804-1820. e16, 2021 | 330 | 2021 |
| Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail J Dong, SJ Zost, AJ Greaney, TN Starr, AS Dingens, EC Chen, RE Chen, ... Nature microbiology 6 (10), 1233-1244, 2021 | 267 | 2021 |
| Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail J Dong, SJ Zost, AJ Greaney, TN Starr, AS Dingens, EC Chen, RE Chen, ... BioRxiv, 2021.01. 27.428529, 2021 | 125 | 2021 |
| Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals EC Chen, P Gilchuk, SJ Zost, N Suryadevara, ES Winkler, CR Cabel, ... Cell Reports 36 (8), 2021 | 76 | 2021 |
| Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JX Reidy, A Trivette, ... BioRxiv, 2020.05. 22.111005, 2020 | 64 | 2020 |
| Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... Cell Reports Medicine 2 (6), 2021 | 63 | 2021 |
| Potent henipavirus neutralization by antibodies recognizing diverse sites on Hendra and Nipah virus receptor binding protein J Dong, RW Cross, MP Doyle, N Kose, JJ Mousa, EJ Annand, ... Cell 183 (6), 1536-1550. e17, 2020 | 38 | 2020 |
| Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking AR Shiakolas, KJ Kramer, NV Johnson, SC Wall, N Suryadevara, ... Nature biotechnology 40 (8), 1270-1275, 2022 | 34 | 2022 |
| Pan-ebolavirus protective therapy by two multifunctional human antibodies P Gilchuk, CD Murin, RW Cross, PA Ilinykh, K Huang, N Kuzmina, ... Cell 184 (22), 5593-5607. e18, 2021 | 28 | 2021 |
| Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress LE Williamson, KM Reeder, K Bailey, MH Tran, V Roy, ME Fouch, N Kose, ... Cell 184 (17), 4430-4446. e22, 2021 | 28 | 2021 |
| Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection TB Engdahl, NA Kuzmina, AJ Ronk, CE Mire, MA Hyde, N Kose, ... Cell reports 35 (5), 2021 | 28 | 2021 |
| Human antibodies protect against aerosolized eastern equine encephalitis virus infection LE Williamson, T Gilliland, PK Yadav, E Binshtein, R Bombardi, N Kose, ... Cell 183 (7), 1884-1900. e23, 2020 | 28 | 2020 |
| Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition KJ Kramer, NV Johnson, AR Shiakolas, N Suryadevara, S Periasamy, ... Cell Reports 37 (1), 2021 | 25 | 2021 |
| Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface SJ Zost, J Dong, IM Gilchuk, P Gilchuk, NJ Thornburg, S Bangaru, N Kose, ... The Journal of Clinical Investigation 131 (15), 2021 | 25 | 2021 |
| Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition NS Chapman, H Zhao, N Kose, JB Westover, B Kalveram, R Bombardi, ... Proceedings of the National Academy of Sciences 118 (14), e2025642118, 2021 | 22 | 2021 |
| Neutralizing COVID-19 convalescent plasma in adults hospitalized with COVID-19: a blinded, randomized, placebo-controlled trial WH Self, AP Wheeler, TG Stewart, H Schrager, J Mallada, CB Thomas, ... Chest 162 (5), 982-994, 2022 | 19 | 2022 |
